You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mrg003

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck Trial in Shanghai (MRG003, Cetuximab injection, Methotrexate Injection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • MRG003
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Feb 21, 2023

Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma Trial in Zhengzhou, Wuhan,

Recruiting
  • Advanced or Metastatic Gastric Cancer
  • Advanced or Metastatic Gastroesophageal Junction Carcinoma
  • MRG003
  • Zhengzhou, Henan, China
  • +4 more
Jan 10, 2022

Advanced or Metastatic Biliary Tract Cancer Trial in China (MRG003)

Recruiting
  • Advanced or Metastatic Biliary Tract Cancer
  • MRG003
  • Beijing, Beijing, China
  • +6 more
Dec 8, 2021

Recurrent or Metastatic Nasopharyngeal Carcinoma Trial in China (MRG003)

Recruiting
  • Recurrent or Metastatic Nasopharyngeal Carcinoma
  • MRG003
  • Chongqing, Chongqing, China
  • +14 more
Nov 18, 2021

Advanced Solid Tumors Trial in Guangzhou (MRG003)

Completed
  • Advanced Solid Tumors
  • MRG003
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 29, 2021

Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (MRG003)

Recruiting
  • Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
  • MRG003
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Apr 29, 2021

NSCLC Trial in Beijing (MRG003)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • MRG003
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 7, 2021